(Central News Agency, Taipei, 5th) The Zhuke Management Bureau and five Taiwanese medical technology start-up companies recently organized a delegation to visit Belgium, a European biotechnology center, to establish contacts in local industry and academia, and to combine Taiwan’s advantages in information and communication technology with new medical innovations to help Belgium produce products. The technical boss was amazed and inquired about purchasing opportunities for new R&D products.
The visiting delegation was commissioned by the Hsinchu Science Park Administration and co-organized by the Asia-Pacific Accelerator Network and the Wallonia Economic and Trade Group of the Belgian Taipei Office, through the Wallonia Export-Investment Agency (AWEX for short) matches science parks, innovation accelerators, European market business legal consultants and various related companies in three places in the French-speaking region of Belgium.
The five new start-ups that visited Belgium this time are all active in the fields of precision health and medical technology, including Dajin Biotechnology, which focuses on precise genetic point-of-care testing technology, and Mirage Startup, which develops 3D medical imaging technology, and is engaged in the research and development of rapid detection of infectious diseases. medical fluids, Senjie Medical, which develops medical devices for removing blood clots, and forward-looking biomedical chips.
Taiwan’s emerging medical technology research and development has performed exceptionally well with the help of the world’s leading information and communication (ICT) industry foundation, which impressed Belgian experts during their visits and exchanges.
For example, Pierre Coulie, an immunology expert at the De Duve Institute founded by Nobel Prize winner Christian de Duve, expressed great appreciation for the 3D medical imaging equipment displayed at the launch of Phantom. His son, a physician, will need one, but it’s not yet on the market. Lian Wenhui, a skin cytology expert and Taiwanese scholar from the Du Wei Institute, was also present for the exchange.
You Jingqiu, chief secretary of the Zhuke Administration Bureau, said that Belgium is the core market of the 27 EU countries and is the country with the highest concentration of biotech and medical companies in Europe and the fastest implementation of clinical trial plans. She believes that Taiwan’s small and medium-sized biotech and medical technology companies should start paying attention to this market earlier.
Zou Hongping, head of the economic and trade team of the Belgian Taipei Office, pointed out that the visiting delegation intensively visited the medical technology clusters in Brussels, Liège and Louvain La Neuve during the five days from October 30 to November 2. and ecosystem exchanges, helping five Taiwanese startups to verify the needs and opportunities of their innovative technologies in the European market in Belgium and the European market. (Editor: Wei Shu) 1121105
